LUCD Logo

Lucid Diagnostics Inc. (LUCD) 

NASDAQ
Market Cap
$44.07M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
644 of 809
Rank in Industry
90 of 107

Largest Insider Buys in Sector

LUCD Stock Price History Chart

LUCD Stock Performance

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Insider Activity of Lucid Diagnostics Inc.

Over the last 12 months, insiders at Lucid Diagnostics Inc. have bought $0 and sold $49,134 worth of Lucid Diagnostics Inc. stock.

On average, over the past 5 years, insiders at Lucid Diagnostics Inc. have bought $8M and sold $53,408 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 571,428 shares for transaction amount of $8M was made by PAVmed Inc. (10 percent owner) on 2021‑10‑18.

List of Insider Buy and Sell Transactions, Lucid Diagnostics Inc.

2023-09-26SaleLapidus Stanleydirector
29,747
0.0667%
$1.45$43,173-15.54%
2023-09-25SaleLapidus Stanleydirector
200
0.0005%
$1.43$286-12.59%
2023-09-21SaleLapidus Stanleydirector
100
0.0002%
$1.44$144-13.19%
2023-09-20SaleLapidus Stanleydirector
3,817
0.0087%
$1.45$5,531-13.79%
2022-09-20SaleLapidus Stanleydirector
33,864
0.0916%
$1.70$57,683-13.29%
2021-10-18PurchasePAVmed Inc.10 percent owner
571,428
4.5992%
$14.00$8M-67.86%

Insider Historical Profitability

<0.0001%
Lapidus Stanleydirector
101592
0.2274%
$0.8405
PAVmed Inc.10 percent owner
27927190
62.5227%
$0.8410<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Luminus Management Llc$581,230.001.38717,657-7.19%-$45,021.500.09
The Vanguard Group$454,285.001.08560,915+68.75%+$185,081.56<0.0001
Geode Capital Management$126,166.000.3155,757+18.11%+$19,348.09<0.0001
Nantahala Capital Management Llc$132,281.000.29149,6980%+$00.01
Jane Street Capital$98,818.000.23122,013+888.36%+$88,819.82<0.0001
Hrt Financial Llc$51,000.000.1263,035New+$51,000.00<0.0001
BlackRock$41,827.000.151,646+120.21%+$22,832.91<0.0001
Verition Fund Management Llc$34,323.000.0842,379+17.18%+$5,031.94<0.0001
LINSCO PRIVATE LEDGER CORP$29,992.000.0737,032+13.49%+$3,565.15<0.0001
Virtu Financial Llc$28,000.000.0734,671+66.4%+$11,173.03<0.01
Geneos Wealth Management Inc$27,419.000.0733,8500%+$0<0.01
Citadel Advisors LLC$23,731.000.0629,301-1.14%-$273.75<0.0001
Tower Research Capital$16,178.000.0419,973+1,867.78%+$15,355.86<0.0001
State Street$14,925.000.0418,428+75.15%+$6,403.95<0.0001
Wells Fargo$11,747.000.0314,505+59.73%+$4,392.67<0.0001
Northern Trust$10,646.000.0313,145New+$10,646.00<0.0001
JONES FINANCIAL COMPANIES LP LLP$3,099.000.013,831New+$3,099.00<0.0001
CWM LLC$1,000.00<0.011,761New+$1,000.00<0.0001
Morgan Stanley$790.00<0.01976+388%+$628.12<0.0001
Cibc Private Wealth Group Llc$283.00<0.01315New+$283.00<0.0001
JPMorgan Chase$28.00<0.0134-27.66%-$10.71<0.0001
Qube Research & Technologies$1.00<0.011-99.04%-$103.00<0.0001
Allworth Financial Lp$128.00<0.01157New+$128.00<0.0001
Thompson Investment Management Inc$1.00<0.011New+$1.00<0.0001
Royal Bank of Canada$0<0.0189-55.05%-$0<0.0001
Newbridge Financial Services Group Inc$40.00<0.0150New+$40.00<0.0001
Advisor Group Holdings Inc$35.00<0.0145-97.75%-$1,520.56<0.0001
Bank of America$3.00<0.013-78.57%-$11.00<0.0001
Maple Capital Management Inc$20.00<0.0125New+$20.00<0.0001